Explainer
Anxiety treatments guide: CBT, SSRIs, SNRIs and what NICE advises
Guidelines put talking therapy, mainly cognitive behavioural therapy (CBT), and SSRI antidepressants at the centre of anxiety treatment.[1][2] For generalized anxiety disorder, NICE says the choice between high-intensity therapy and medication should follow the person's preference, because neither has been shown to be better.[3] Benzodiazepines work quickly but carry dependence risks; NICE and WHO advise against routine use.[4][5][6]
Anxiety disorders respond to treatment, and the main options have been tested in many randomised trials.[7][8] This guide sets out what the UK’s National Institute for Health and Care Excellence (NICE), WHO, NIMH and the NHS recommend, and what the trial evidence shows. Medicine names and session numbers come from the guidelines and trials named, in the populations they studied.
This page is general information, not medical advice. Do not start, stop or change a treatment without talking to a clinician.
If you are in crisis or thinking about suicide, help is available now. In the US, call or text 988. In the UK and Ireland, call Samaritans on 116 123. Elsewhere, see findahelpline.com.
How care is organised: stepped care
NICE recommends “stepped care” for generalized anxiety disorder: start with the least intrusive treatment that works, and step up if needed.[9] After an assessment, education and monitoring, the first treatments are low-intensity: self-help based on CBT, guided self-help with a practitioner, or group courses.[10] If those do not help, or the anxiety is seriously affecting daily life, the next step is either one-to-one therapy or medicine.[3] In the UK the NHS says a GP will usually suggest talking therapy before medicine, and adults in England can refer themselves to NHS talking therapies.[11][12]
NICE CG113 step 3 applies to GAD with marked functional impairment or an inadequate response to step 2. It offers either an individual high-intensity psychological intervention or drug treatment, chosen by preference because there is no evidence either mode is better.[3] For panic disorder, NICE recommends CBT totalling 7 to 14 hours, usually in weekly sessions completed within 4 months.[13] For social anxiety disorder, a separate guideline (CG159) recommends individual CBT built specifically for social anxiety, based on the Clark and Wells or Heimberg models, over group CBT.[14]
Talking therapies
Cognitive behavioural therapy helps people notice and question inaccurate or harmful automatic thoughts and change the behaviour patterns that keep anxiety going.[15] WHO says CBT-based therapies, including exposure therapy, have the most evidence across anxiety disorders.[1] For GAD, NICE recommends CBT or applied relaxation, usually 12 to 15 weekly one-hour sessions with a trained practitioner.[16]
| Evidence | What it found |
|---|---|
| 2018 meta-analysis, 41 placebo-controlled trials | Moderate overall effect of CBT; large for GAD and OCD, smaller for panic disorder and social anxiety[7] |
| Same meta-analysis | Exposure-based treatments had larger effects than cognitive techniques, though not significantly[17] |
| TAME trial, 276 adults (2022) | An 8-week mindfulness-based stress reduction course was noninferior to escitalopram[18] |
NIMH also lists acceptance and commitment therapy (ACT), which uses mindfulness and goal setting, as an option for GAD with a growing evidence base.[19] For panic disorder, interoceptive exposure deliberately brings on the bodily sensations of panic so that people learn to react to them differently.[20] NICE does not recommend routinely offering mindfulness-based interventions for social anxiety disorder.[21] For an overview of other talking therapies, see types of therapy explained; for depression, see the depression treatments guide.
Medicines
The medicines used most for anxiety are antidepressants called SSRIs and SNRIs. They can take several weeks to work and may cause side effects such as headaches, nausea or trouble sleeping.[22] The NHS says many side effects ease after a couple of weeks.[23] It is not common, but some people have suicidal thoughts when they start an antidepressant; the NHS says people aged 24 or under may be most at risk and should speak to a doctor straight away if this happens.[24] The NHS also says not to stop an antidepressant suddenly without talking to a doctor.[25]
NICE CG113 recommends an SSRI for GAD when drug treatment is chosen, considering sertraline first on cost-effectiveness grounds, then an alternative SSRI or an SNRI.[2] Pregabalin may be considered if SSRIs and SNRIs are not tolerated; it has been a Class C controlled drug in the UK since April 2019.[26] For social anxiety disorder, CG159 names escitalopram or sertraline.[27] A 2019 Lancet network meta-analysis of 89 trials in adult GAD outpatients found duloxetine, pregabalin, venlafaxine and escitalopram effective with relatively good acceptability.[8] Quetiapine had the largest effect but was poorly tolerated, as were paroxetine and benzodiazepines.[28] NIMH notes that buspirone, a non-sedating option, takes 3 to 4 weeks to be fully effective.[29]
Benzodiazepines: fast but discouraged
Benzodiazepines can reduce anxiety quickly, but some people build tolerance or become dependent, so NIMH says they may be prescribed only briefly.[29] In 2020 the FDA required updated boxed warnings for the whole class, covering abuse, addiction, physical dependence and withdrawal.[6] The FDA says dependence can develop within days to weeks of steady use, even as prescribed, and that stopping abruptly can cause withdrawal reactions including seizures.[30]
NICE says not to offer a benzodiazepine for GAD except as a short-term measure during a crisis, and not to prescribe one for panic disorder.[4][31] WHO generally does not recommend them for anxiety disorders.[5]
Digital and new treatments
WHO says CBT-based help can also be delivered online and through apps.[32] In September 2024 the FDA cleared DaylightRx, a prescription CBT app from Big Health, as the first digital treatment for GAD, for adults aged 22 and older alongside usual care.[33] General wellness apps are a different category; see the meditation apps buyer’s guide.
New drugs are in late-stage trials. In 2026 Definium Therapeutics reported positive results from two phase 3 trials of a single dose of DT120, an LSD-based tablet, in GAD.[34][35] It is not approved, and the company has said it expects to file for approval in the first half of 2027.[36] The anxiety research and policy tracker follows these developments.
Read next
Next in the crash course
Cognitive behavioural therapy (CBT)
Cognitive behavioural therapy is a structured talking therapy that changes unhelpful thoughts and behaviours. How it works, what it treats and the evidence.
Questions readers ask
What is the first treatment for generalized anxiety disorder?
NICE uses stepped care, starting with the least intrusive effective option. After education and monitoring, it recommends low-intensity help such as guided self-help or psychoeducational groups. The NHS says a GP will usually suggest talking therapy before medicine.[9][10][11]
Is CBT or medication better for anxiety?
For GAD that needs high-intensity treatment, NICE says to base the choice on the person's preference because there is no evidence that either CBT or drug treatment is better. NIMH notes many people benefit from a combination.[3][37]
Which medicine does NICE suggest first for GAD?
NICE recommends an SSRI, considering sertraline first because it is the most cost-effective. If sertraline does not work, NICE suggests another SSRI or an SNRI. Any prescribing decision is for a clinician.[2]
How long do SSRIs take to work for anxiety?
NIMH says SSRIs and SNRIs may take several weeks to start working. They can cause side effects such as headaches, nausea or difficulty sleeping.[22]
Why are benzodiazepines not recommended for anxiety?
WHO says they carry a high potential for dependence and have limited long-term effectiveness. The FDA warns that physical dependence can develop within days to weeks, even as prescribed. NICE says to use them for GAD only as a short-term measure in a crisis, and not for panic disorder.[5][30][4][31]
Can I stop my antidepressant if I feel better?
The NHS says not to stop an antidepressant suddenly or without talking to your doctor, who can plan a gradual reduction.[25]
Is there an FDA-cleared app for anxiety?
Yes. In September 2024 the FDA cleared Big Health's DaylightRx, a prescription app that delivers CBT, as the first digital treatment for generalized anxiety disorder, for adults 22 and older alongside usual care.[33]
Sources
· 37 claims from 12 publishers
Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.
- [1]
WHO says the psychological treatments with the most evidence across anxiety disorders are based on cognitive-behavioural therapy, including exposure therapy, in which people learn to face their fears. confirmedas of 2026-09-15
- Anxiety disorders (fact sheet) · World Health Organization · 2026-09-15 · Diagnosis and treatment (retrieved 2026-10-11)
- [2]
NICE recommends that people with GAD who choose drug treatment be offered an SSRI, considering sertraline first because it is the most cost-effective; if it does not work, an alternative SSRI or an SNRI. confirmedas of 2026-10-11
- Generalised anxiety disorder and panic disorder in adults: management (CG113), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.2.23 (retrieved 2026-10-11)
- Generalised anxiety disorder and panic disorder in adults: management (CG113), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.2.24 (retrieved 2026-10-11)
- [3]
For GAD with marked functional impairment or no response to low-intensity help, NICE recommends offering either a high-intensity psychological intervention or drug treatment, based on preference, because there is no evidence either is better. confirmedas of 2026-10-11
- Generalised anxiety disorder and panic disorder in adults: management (CG113), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.2.17 (retrieved 2026-10-11)
- [4]
NICE says not to offer a benzodiazepine for GAD in primary or secondary care except as a short-term measure during crises, and not to offer an antipsychotic for GAD in primary care. confirmedas of 2026-10-11
- Generalised anxiety disorder and panic disorder in adults: management (CG113), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.2.26 (retrieved 2026-10-11)
- Generalised anxiety disorder and panic disorder in adults: management (CG113), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.2.27 (retrieved 2026-10-11)
- [5]
WHO says benzodiazepines are generally not recommended for anxiety disorders because of their high potential for dependence and limited long-term effectiveness. confirmedas of 2026-09-15
- Anxiety disorders (fact sheet) · World Health Organization · 2026-09-15 · Diagnosis and treatment (retrieved 2026-10-11)
- [6]
In September 2020 the FDA required the Boxed Warning for all benzodiazepine medicines to be updated to address the serious risks of abuse, addiction, physical dependence and withdrawal reactions. confirmedas of 2020-09-23
- FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class · US Food and Drug Administration · 2020-09-23 · What safety concern is FDA announcing? (retrieved 2026-10-11)
- [7]
A 2018 meta-analysis of 41 placebo-controlled trials (2,843 patients) found CBT had a moderate effect on anxiety-related disorders (Hedges' g 0.56), with large effects for OCD, GAD and acute stress disorder and small-to-moderate effects for PTSD, social anxiety and panic disorder. confirmedas of 2018-06-01
- Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials (Depress Anxiety, 2018) · Depression and Anxiety (via PubMed) · 2018-06-01 · Abstract (retrieved 2026-10-11)
- Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials (Depress Anxiety, 2018) · Depression and Anxiety (via PubMed) · 2018-06-01 · Abstract (retrieved 2026-10-11)
- [8]
A 2019 Lancet network meta-analysis of 89 trials (25,441 adult outpatients with GAD) found duloxetine, pregabalin, venlafaxine and escitalopram more effective than placebo with relatively good acceptability. confirmedas of 2019-02-23
- Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis (Lancet, 2019) · The Lancet (via PubMed) · 2019-02-23 · Findings (retrieved 2026-10-11)
- [9]
NICE guideline CG113 tells clinicians to follow a stepped-care model for GAD, offering the least intrusive, most effective intervention first. confirmedas of 2026-10-11
- Generalised anxiety disorder and panic disorder in adults: management (CG113), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.2.1 (retrieved 2026-10-11)
- [10]
For GAD that has not improved after education and active monitoring, NICE recommends offering low-intensity psychological interventions as first line, guided by the person's preference - non-facilitated self-help, guided self-help or psychoeducational groups. confirmedas of 2026-10-11
- Generalised anxiety disorder and panic disorder in adults: management (CG113), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.2.12 (retrieved 2026-10-11)
- [11]
The NHS says the main GAD treatments a GP may offer are talking therapies, usually CBT, and medicines, usually an SSRI antidepressant, and that a GP will usually advise trying talking therapies first. confirmedas of 2026-10-11
- Generalised anxiety disorder (GAD) · NHS (nhs.uk) · Treatment for generalised anxiety disorder (GAD) (retrieved 2026-10-11)
- Generalised anxiety disorder (GAD) · NHS (nhs.uk) · Treatment for generalised anxiety disorder (GAD) (retrieved 2026-10-11)
- [12]
In England, adults aged 18 or over can refer themselves to NHS talking therapies for anxiety without a GP referral, according to the NHS. confirmedas of 2026-10-11
- Generalised anxiety disorder (GAD) · NHS (nhs.uk) · Other ways to get help (retrieved 2026-10-11)
- [13]
For panic disorder, NICE recommends CBT of 7 to 14 hours in total, usually weekly sessions of 1 to 2 hours completed within 4 months, delivered by trained and supervised therapists. confirmedas of 2026-10-11
- Generalised anxiety disorder and panic disorder in adults: management (CG113), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.3.15 (retrieved 2026-10-11)
- Generalised anxiety disorder and panic disorder in adults: management (CG113), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.3.16 (retrieved 2026-10-11)
- [14]
NICE recommends offering adults with social anxiety disorder individual CBT developed specifically for social anxiety (based on the Clark and Wells or Heimberg models), and not routinely offering group CBT in preference to individual CBT. confirmedas of 2026-10-11
- Social anxiety disorder: recognition, assessment and treatment (CG159), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.3.2 (retrieved 2026-10-11)
- [15]
NIMH describes CBT as a research-supported psychotherapy commonly used for GAD that helps people notice and question inaccurate or harmful automatic thoughts, and calls it the "gold standard" psychotherapy. confirmedas of 2026-10-11
- Generalized Anxiety Disorder: What You Need to Know · National Institute of Mental Health · Psychotherapy (retrieved 2026-10-11)
- Generalized Anxiety Disorder: What You Need to Know · National Institute of Mental Health · Psychotherapy (retrieved 2026-10-11)
- [16]
NICE recommends that people with GAD who choose a high-intensity psychological intervention be offered CBT or applied relaxation, usually 12 to 15 weekly one-hour sessions delivered by trained practitioners. confirmedas of 2026-10-11
- Generalised anxiety disorder and panic disorder in adults: management (CG113), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.2.18 (retrieved 2026-10-11)
- Generalised anxiety disorder and panic disorder in adults: management (CG113), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.2.19 (retrieved 2026-10-11)
- [17]
In the 2018 CBT meta-analysis, treatments that mainly used exposure had larger effects than those using cognitive techniques, though the difference was not statistically significant. confirmedas of 2018-06-01
- Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials (Depress Anxiety, 2018) · Depression and Anxiety (via PubMed) · 2018-06-01 · Abstract (retrieved 2026-10-11)
- [18]
In the TAME randomised trial of 276 adults with anxiety disorders at three US academic centres, an 8-week mindfulness-based stress reduction (MBSR) course was noninferior to the SSRI escitalopram on clinician-rated anxiety severity. confirmedas of 2023-01-01
- Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial (JAMA Psychiatry, 2023) · JAMA Psychiatry (via PubMed) · 2023-01-01 · Conclusions and relevance (retrieved 2026-10-11)
- Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial (JAMA Psychiatry, 2023) · JAMA Psychiatry (via PubMed) · 2023-01-01 · Design, setting and participants (retrieved 2026-10-11)
- [19]
NIMH describes acceptance and commitment therapy (ACT) as another option for GAD that uses mindfulness and goal setting, with a growing body of research supporting it. confirmedas of 2026-10-11
- Generalized Anxiety Disorder: What You Need to Know · National Institute of Mental Health · Psychotherapy (retrieved 2026-10-11)
- [20]
NIMH says CBT is commonly used to treat panic disorder, and that techniques include exposure therapy and interoceptive exposure, which exposes people to the bodily sensations associated with panic attacks. confirmedas of 2026-10-11
- Panic Disorder: When Fear Overwhelms · National Institute of Mental Health · Psychotherapy (retrieved 2026-10-11)
- Panic Disorder: When Fear Overwhelms · National Institute of Mental Health · Psychotherapy (retrieved 2026-10-11)
- [21]
NICE advises clinicians not to routinely offer mindfulness-based interventions or supportive therapy to treat social anxiety disorder, nor benzodiazepines, anticonvulsants, tricyclics or antipsychotics in adults. confirmedas of 2026-10-11
- Social anxiety disorder: recognition, assessment and treatment (CG159), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.6.3 (retrieved 2026-10-11)
- Social anxiety disorder: recognition, assessment and treatment (CG159), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.6.2 (retrieved 2026-10-11)
- [22]
NIMH says SSRI and SNRI antidepressants can help treat GAD symptoms, may take several weeks to start working and may cause side effects such as headaches, nausea or difficulty sleeping. confirmedas of 2026-10-11
- Generalized Anxiety Disorder: What You Need to Know · National Institute of Mental Health · Medication (retrieved 2026-10-11)
- [23]
The NHS lists common antidepressant side effects including feeling agitated or anxious, difficulty sleeping, headaches, nausea, dizziness and sexual problems, and says many ease after a couple of weeks. confirmedas of 2026-10-11
- Antidepressants · NHS (nhs.uk) · Side effects of antidepressants (retrieved 2026-10-11)
- [24]
The NHS says it is not common, but some people may have suicidal thoughts or an urge to self-harm when starting an antidepressant, that people aged 24 or under may be most at risk, and that they should speak to a doctor straight away. confirmedas of 2026-10-11
- Antidepressants · NHS (nhs.uk) · Suicidal thoughts (retrieved 2026-10-11)
- [25]
The NHS says not to stop an antidepressant suddenly or without talking to a doctor, who can agree a plan to reduce the dose gradually. confirmedas of 2026-10-11
- Antidepressants · NHS (nhs.uk) · Stopping or coming off antidepressants (retrieved 2026-10-11)
- [26]
NICE says pregabalin can be considered for GAD if a person cannot tolerate SSRIs or SNRIs, noting it has been a Class C controlled substance in the UK since April 2019. confirmedas of 2026-10-11
- Generalised anxiety disorder and panic disorder in adults: management (CG113), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.2.25 (retrieved 2026-10-11)
- [27]
For adults with social anxiety disorder who want medication, NICE recommends offering an SSRI (escitalopram or sertraline). confirmedas of 2026-10-11
- Social anxiety disorder: recognition, assessment and treatment (CG159), recommendations · National Institute for Health and Care Excellence (NICE) · Recommendation 1.3.6 (retrieved 2026-10-11)
- [28]
The same 2019 meta-analysis found quetiapine had the largest effect on anxiety scores but was poorly tolerated, and that paroxetine and benzodiazepines were effective but also poorly tolerated compared with placebo. confirmedas of 2019-02-23
- Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis (Lancet, 2019) · The Lancet (via PubMed) · 2019-02-23 · Findings (retrieved 2026-10-11)
- [29]
NIMH says benzodiazepines can rapidly reduce anxiety but some people build tolerance or become dependent, so they may be prescribed only briefly; buspirone is not a sedative, is less likely to be addictive and takes 3 to 4 weeks to be fully effective. confirmedas of 2026-10-11
- Generalized Anxiety Disorder: What You Need to Know · National Institute of Mental Health · Medication (retrieved 2026-10-11)
- Generalized Anxiety Disorder: What You Need to Know · National Institute of Mental Health · Medication (retrieved 2026-10-11)
- [30]
The FDA says physical dependence on benzodiazepines can develop when they are taken steadily for several days to weeks, even as prescribed, and that stopping abruptly or reducing the dose too quickly can cause withdrawal reactions including seizures. confirmedas of 2020-09-23
- FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class · US Food and Drug Administration · 2020-09-23 · What safety concern is FDA announcing? (retrieved 2026-10-11)
- [31]
NICE says benzodiazepines are associated with a worse long-term outcome and should not be prescribed for panic disorder. confirmedas of 2026-10-11
- Generalised anxiety disorder and panic disorder in adults: management (CG113), recommendations · National Institute for Health and Care Excellence (NICE) · Panic disorder, step 2 (retrieved 2026-10-11)
- [32]
WHO says psychological treatments for anxiety can be delivered individually or in groups, in person or online, and through self-help manuals, websites and apps. confirmedas of 2026-09-15
- Anxiety disorders (fact sheet) · World Health Organization · 2026-09-15 · Diagnosis and treatment (retrieved 2026-10-11)
- [33]
In September 2024 the FDA cleared Big Health's DaylightRx, a prescription app delivering CBT, as the first FDA-cleared digital treatment for generalized anxiety disorder, for adults aged 22 and older as an adjunct to usual care. confirmedas of 2024-09-05
- First Digital Treatment for Generalized Anxiety Disorder Cleared by the FDA · Psychiatric Times · 2024-09-05 · Article (retrieved 2026-10-11)
- DaylightRx (digital CBT anxiety treatment) · Big Health · Indications (retrieved 2026-10-11)
- [34]
Definium Therapeutics reported on 12 August 2026 that its first phase 3 GAD trial, Voyage (107 participants per arm), met its primary endpoint - a single 100 µg dose of DT120 reduced HAM-A anxiety scores by 11.6 points at week 12 versus 6.2 on placebo, a 5.4-point difference. reportedas of 2026-08-12
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder · Definium Therapeutics (press release) · 2026-08-12 · Press release (retrieved 2026-10-11)
- Positive Topline Results From Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder · Psychiatric Times · 2026-09-14 · Article (retrieved 2026-10-11)
- [35]
Definium reported on 14 September 2026 that its second phase 3 GAD trial, Panorama (245 participants), met its primary endpoint - a single 100 µg dose of DT120 reduced HAM-A scores by 9.8 points at week 12 versus 4.7 on placebo, a 5.1-point difference. confirmedas of 2026-09-14
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder (Form 8-K, Exhibit 99.1) · Definium Therapeutics (SEC filing) · 2026-09-14 · Highlights from Panorama Topline Results (retrieved 2026-10-11)
- Positive Topline Results From Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder · Psychiatric Times · 2026-09-14 · Panorama Results (retrieved 2026-10-11)
- Positive Topline Results From Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder · Psychiatric Times · 2026-09-14 · About the Panorama Study (retrieved 2026-10-11)
- [36]
Definium said in September 2026 that a pre-NDA meeting with the FDA was scheduled for the fourth quarter of 2026 and that it anticipated filing a New Drug Application in the first half of 2027. confirmedas of 2026-09-14
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder (Form 8-K, Exhibit 99.1) · Definium Therapeutics (SEC filing) · 2026-09-14 · Headline (retrieved 2026-10-11)
- [37]
NIMH says psychotherapy and medication are the two main treatments for anxiety and that many people benefit from a combination of the two. confirmedas of 2026-10-11
- I'm So Stressed Out! (fact sheet) · National Institute of Mental Health · Recognize When You Need More Help (retrieved 2026-10-11)
Revision history (1)
- Page created.
Created Oct 11, 2026. Last reviewed by an editor on Oct 11, 2026. Next scheduled review: Jan 11, 2027.
Cite this page
"Anxiety treatments guide: CBT, SSRIs, SNRIs and what NICE advises." ContentLora, updated Oct 11, 2026. https://contentlora.com/explain/anxiety-treatments-guide
Spotted an error? Suggest a correction or emailcorrections@contentlora.com.